Vision Medicals

company

About

Vision Medicals is a gene technology and precision medicine company.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
¥200M
Industries
Health Care
Founded date
Jan 1, 2018
Number Of Employee
51 - 100
Operating Status
Active

Vision Medicals is a provider of pathogenic gene diagnostic services, focusing on infection-precise medical treatment, high-throughput sequencing-based pathogen metagenomics and CRISPR-based rapid diagnosis and other new technologies, effectively improving the detection ability of clinical pathogens and shortening The reporting cycle accelerated the development of the infection-accurate medical industry. The company developed a pathogenic nucleic acid enrichment technology with independent intellectual property rights for the detection of pathogenic micronucleic acids in clinical samples. The pathogen macro was established through the accumulation of pathogen detection big data. Genomics intelligent analysis and reporting system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥200M
Vision Medicals has raised a total of ¥200M in funding over 2 rounds. Their latest funding was raised on Aug 12, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 12, 2020 Series B ¥200M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Vision Medicals is funded by 1 investors. CICC Qichen are the most recent investors.
Investor Name Lead Investor Funding Round
CICC Qichen Series B